Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques

Long-acting antiretrovirals can improve therapy and prevention for HIV-1 infection. Current long-acting cabotegravir (CAB LAP) can be administered every other month. Previously, we demonstrated that a myristoylated CAB prodrug encased in poloxamer 407 provided extended plasma drug concentrations. We...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:AIDS
Päätekijät: McMillan, JoEllyn, Szlachetka, Adam, Zhou, Tian, Morsey, Brenda, Lamberty, Benjamin, Callen, Shannon, Gautam, Nagsen, Alnouti, Yazen, Edagwa, Benson, Gendelman, Howard E., Fox, Howard S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521853/
https://ncbi.nlm.nih.gov/pubmed/30289818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000002032
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia